Omeprazole Impurity D is a benzimidazole-based compound derived from the parent drug through oxidative modification of the sulfinyl moiety, resulting in a sulfone functional group. Its structure features a 5-methoxybenzimidazole ring system linked to a 4-methoxy-3,5-dimethylpyridine via a methylsulfonyl bridge, with retained dimethylamino functionality on the pyridine ring. This impurity arises from over-oxidation during API synthesis or storage, distinguishing itself by an additional oxygen atom in the sulfonyl group compared to omeprazole. It serves as a critical HPLC reference standard for quantifying oxidative degradation pathways in omeprazole formulations.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | O0151000 โ | 15 MG | EUR 90.00 |
| USP | 1478516 โ | 15 mg | USD 855.00 |
CC1=CN=C(C(=C1OC)C)CS(=O)(=O)C2=NC3=C(N2)C=C(C=C3)OC
InChI=1S/C17H19N3O4S/c1-10-8-18-15(11(2)16(10)24-4)9-25(21,22)17-19-13-6-5-12(23-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)
IXEQEYRTSRFZEO-UHFFFAOYSA-N